Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
¥ 407
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Slightly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'cheap' on
Data is available to registered users only
Buy
Sell